BG63917B1 - 1-ар(алк)ил-имидазолин-2-они с дизаместен аминов остатък на 4-място, с антиконвулсивно действие и метод за получаването им - Google Patents

1-ар(алк)ил-имидазолин-2-они с дизаместен аминов остатък на 4-място, с антиконвулсивно действие и метод за получаването им Download PDF

Info

Publication number
BG63917B1
BG63917B1 BG102287A BG10228798A BG63917B1 BG 63917 B1 BG63917 B1 BG 63917B1 BG 102287 A BG102287 A BG 102287A BG 10228798 A BG10228798 A BG 10228798A BG 63917 B1 BG63917 B1 BG 63917B1
Authority
BG
Bulgaria
Prior art keywords
imidazolin
morpholino
chlorophenyl
preparation
alk
Prior art date
Application number
BG102287A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102287A (en
Inventor
Hans-Joachim Lankau
Manfred Menzer
Klaus Unverferth
Karl Gewald
Harry Schaefer
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG63917(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of BG102287A publication Critical patent/BG102287A/xx
Publication of BG63917B1 publication Critical patent/BG63917B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG102287A 1995-09-05 1998-02-27 1-ар(алк)ил-имидазолин-2-они с дизаместен аминов остатък на 4-място, с антиконвулсивно действие и метод за получаването им BG63917B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
PCT/EP1996/003295 WO1997009314A1 (de) 1995-09-05 1996-07-26 Neue, antikonvulsiv wirkende 1-ar(alk)yl-imidazolin-2-one, die in 4-stellung einen disubstituierten amin-rest enthalten, und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
BG102287A BG102287A (en) 1998-09-30
BG63917B1 true BG63917B1 (bg) 2003-06-30

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102287A BG63917B1 (bg) 1995-09-05 1998-02-27 1-ар(алк)ил-имидазолин-2-они с дизаместен аминов остатък на 4-място, с антиконвулсивно действие и метод за получаването им

Country Status (32)

Country Link
EP (1) EP0863880B1 (zh)
JP (1) JP4030578B2 (zh)
CN (1) CN1103762C (zh)
AR (1) AR003502A1 (zh)
AT (1) ATE254606T1 (zh)
AU (1) AU700602B2 (zh)
BG (1) BG63917B1 (zh)
BR (1) BR9610359A (zh)
CA (1) CA2184871C (zh)
CZ (1) CZ291839B6 (zh)
DE (2) DE19532668A1 (zh)
DK (1) DK0863880T3 (zh)
EA (1) EA000535B1 (zh)
EE (1) EE03562B1 (zh)
ES (1) ES2208758T3 (zh)
FR (1) FR13C0049I2 (zh)
GE (1) GEP20022652B (zh)
HK (1) HK1015776A1 (zh)
HU (1) HU225956B1 (zh)
IL (1) IL123333A (zh)
LT (1) LT4482B (zh)
LU (1) LU92263I2 (zh)
NO (1) NO313829B1 (zh)
NZ (1) NZ315624A (zh)
PL (1) PL188287B1 (zh)
PT (1) PT863880E (zh)
SK (1) SK284868B6 (zh)
TR (1) TR199800476T1 (zh)
TW (1) TW422838B (zh)
UA (1) UA46790C2 (zh)
WO (1) WO1997009314A1 (zh)
ZA (1) ZA967014B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
UA87982C2 (ru) * 2003-07-11 2009-09-10 Берингер Ингельхайм Ветмедика Гмбх Способ лечения или предотвращения расстройств центральной нервной системы производными 1-ар(алк)-4-пиперидиноимидазолин-2-она, фармацевтическая композиция
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
RU2014109079A (ru) 2011-08-12 2015-09-20 Бёрингер Ингельхайм Ветмедика Гмбх Фармацевтическая композиция с маскированным вкусом
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
EP0863880A1 (de) 1998-09-16
EE9800063A (et) 1998-08-17
PL325413A1 (en) 1998-07-20
ZA967014B (en) 1997-08-18
DE59610827D1 (de) 2003-12-24
CZ66198A3 (cs) 1998-07-15
EP0863880B1 (de) 2003-11-19
TR199800476T1 (xx) 1998-06-22
DK0863880T3 (da) 2004-03-22
LT98047A (en) 1998-10-26
SK21698A3 (en) 1998-10-07
NO313829B1 (no) 2002-12-09
UA46790C2 (uk) 2002-06-17
CA2184871C (en) 2001-08-21
ATE254606T1 (de) 2003-12-15
AR003502A1 (es) 1998-08-05
CA2184871A1 (en) 1997-03-06
HU225956B1 (en) 2008-01-28
NZ315624A (en) 1998-11-25
BR9610359A (pt) 1999-07-06
CZ291839B6 (cs) 2003-06-18
TW422838B (en) 2001-02-21
ES2208758T3 (es) 2004-06-16
CN1103762C (zh) 2003-03-26
DE19532668A1 (de) 1997-03-06
AU6737596A (en) 1997-03-27
JPH11512101A (ja) 1999-10-19
NO980906L (no) 1998-03-02
IL123333A (en) 2001-10-31
IL123333A0 (en) 1998-09-24
BG102287A (en) 1998-09-30
HK1015776A1 (en) 1999-10-22
EA000535B1 (ru) 1999-10-28
EA199800271A1 (ru) 1998-10-29
CN1200728A (zh) 1998-12-02
WO1997009314A1 (de) 1997-03-13
FR13C0049I1 (zh) 2013-09-27
PL188287B1 (pl) 2005-01-31
GEP20022652B (en) 2002-03-25
HUP9802941A2 (hu) 1999-09-28
NO980906D0 (no) 1998-03-02
FR13C0049I2 (fr) 2014-03-28
PT863880E (pt) 2004-04-30
SK284868B6 (sk) 2006-01-05
LT4482B (lt) 1999-03-25
HUP9802941A3 (en) 1999-10-28
JP4030578B2 (ja) 2008-01-09
LU92263I2 (fr) 2013-10-07
AU700602B2 (en) 1999-01-07
EE03562B1 (et) 2001-12-17
MX9801742A (es) 1998-08-30

Similar Documents

Publication Publication Date Title
JP2637737B2 (ja) 新規な薬剤
EP0054951A1 (en) Dibenz(b,f)(1,4)oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same
EP0025111A1 (en) 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
EP0000220B1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3558652A (en) N-monosubstituted pyrrylaminoethanols
BG63917B1 (bg) 1-ар(алк)ил-имидазолин-2-они с дизаместен аминов остатък на 4-място, с антиконвулсивно действие и метод за получаването им
DE2851028A1 (de) Neue indolo eckige klammer auf 2.3-a eckige klammer zu chinolizidine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitung
NL8001981A (nl) Benzoxepinederivaat en farmaceutische preparaten op basis daarvan.
DE2424671C3 (de) 5,6-Dihydro-s-triazolo [5,1-a]isochinolinderivat e und Verfahren zu deren Herstellung
FI60863C (fi) Foerfarande foer framstaellning av nya bentshydryloxialkylaminderivat med foerlaengd antihistamineffekt
US3213140A (en) 2-phenyl-4, 6-dichlorophenoxyethylamine and salts thereof
CH627175A5 (zh)
US4259257A (en) 1-Phenyl-2-amino-1,3-propanediol-N-aryloxyalkyl derivatives
EP0338435A1 (de) 3.4-Dihydroxypyrrolidin-2-on-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung sowie die bei der Herstellung anfallenden Zwischenprodukte
US4161532A (en) N-(1'-ethyl-2'-oxo-5'-pyrrolidinylmethyl) benzamide compounds and derivatives, method of preparation and pharmaceutical preparations
DE1643265C3 (de) Kernsubstituierte 2-Aminomethylbenzhydrole, Verfahren zu deren Herstellung und Arzneimittel auf der Basis dieser Verbindungen
US3074953A (en) 5-(3'-(4-phenyl-4-carbethoxy piperidino)-propylidene) dibenzo (a,d) (1,4) cycloheptadiene
FI64591B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(2-bensofuryl)-1-pyrrolinderivat
HU191585B (en) Process for producing tetramethyl-proline-3-carboxamide derivatives and new cardiotherapeutic compositions containing them
FR2567517A1 (fr) Sels d'ammonium derives de hexahydrodibenzodioxane, leurs intermediaires, leur preparation et leur application en therapeutique
MXPA98001742A (en) New 1-ar (alqu) il-imidazolin-2-onas, which are conposition 4, contains a rested amino resort, of anticonvulsive effect and procedures for suelaborac
HU181441B (en) Process for producing substituted quinolizidine and indolizidine derivatives
CS216172B2 (cs) Způsob výroby N-substituovaných N-2-(2-furylethyl)-aminů
DE2337414A1 (de) 2-imidazolidinon-derivate und verfahren zu deren herstellung
EP0175331A1 (en) Piperazine Derivatives